GAD1 and diabetes mellitus: The recent progress in better defining novel T2D subtypes based on underpinning disease mechanisms such as age at diabetes diagnosis, GAD antibodies, C-peptide and genetic factors need to be explored for their utility in predicting other stratified glucose lowering responses (26).